Legal Representation
Attorney
Steven W. Caldwell
USPTO Deadlines
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 11, 2007 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 7, 2007 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 22, 2007 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Mar 14, 2007 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Mar 14, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 31, 2006 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Sep 27, 2006 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Sep 27, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 7, 2006 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Mar 28, 2006 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Apr 4, 2006 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 28, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 27, 2006 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 22, 2005 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 22, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 22, 2005 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 22, 2005 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 28, 2005 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 28, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 28, 2004 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 6, 2004 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 16, 2004 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Apr 19, 2004 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 16, 2004 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 16, 2004 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Medical foods for use in the dietary management of patients with neurological, hematological, cognitive or physical diseases or conditions; pharmaceutical preparations for the treatment or prevention of neurological, hematological, cognitive, or physical diseases or conditions
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005